Peroxisome Proliferator-Activated Receptors (PPARS): From metabolic control to epidermal wound healing

Swiss Medical Weekly

Volumn 132, Issue 7-8, 2002, Pages 83-91

  Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Inflammation; Keratinocytes; Lipid metabolism; Metabolic diseases; Skin

Indexed keywords

FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; ROSIGLITAZONE;

AMINO ACID METABOLISM; ANIMAL TISSUE; CELL DIFFERENTIATION; CELL MIGRATION; CHOLESTEROL TRANSPORT; HYPERLIPIDEMIA; IMMUNE RESPONSE; INFLAMMATION; KERATINOCYTE; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; REVIEW; SKIN INJURY; WOUND HEALING;

EID: 0037160785     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Roles of PPARs in health and disease
2. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
3. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
4. A unified nomenclature system for the nuclear receptor superfamily
5. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
6. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
7. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
8. Peroxisome proliferator-activated receptor agonist
9. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
10. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors
11. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha
12. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid
13. A structural role for hormone in the thyroid hormone receptor
14. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
15. Peroxisome proliferator-activated receptor a mediates the adaptive response to fasting
16. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
17. Transcriptional regulation of adipogenesis
18. PPAR-gamma is required for placental, cardiac, and adipose tissue development
19. PPAR-gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
20. The peroxisome proliferator-activated receptor a regulates amino acid metabolism
21. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans
22. Regulation of expression of genes for enzymes of the mammalian urea cycle in permanent cell-culture lines of hepatic and non-hepatic origin
23. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids
24. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms
25. Hypoglycemia-associated hyperammonemia caused by impaired expression of ornithine cycle enzyme genes in C/EBP-alpha knockout mice
26. Effect of long-chain fatty acids on triglyceride accumulation, gluconeogenesis, and ureagenesis in bovine hepatocytes
27. Effect of fatty acids on the disposition of ammonia
28. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action
29. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood
30. Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat
31. Epidermal barrier ontogenesis: Maturation in serum-free media and acceleration by glucocorticoids and thyroid hormone but not selected growth factors
32. Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone
33. Skin abnormalities generated by temporally controlled RXR-alpha mutations in mouse epidermis
34. RXRα ablation in skin kerotinocytes results in alopecia and epidermal alterations
35. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development
36. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators
37. Impaired skin wound healing in PRARα and PPARβ mutant mice
38. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model
39. Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells
40. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid
41. Activators of the nuclear hormone receptors PPAR-alpha and FXR accelerate the development of the fetal epidermal permeability barrier
42. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPAR-alpha
43. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development
44. PPAR-gamma is required for the differentiation of adipose tissue in vivo and in vitro
45. Stimulation of PPAR-alpha promotes epidermal keratinocyte differentiation in vivo
46. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta)
47. The PPARα-leukotriene B4 pathway to inflammation control
48. Ceramide in the eukaryotic stress response
49. Critical roles of PPARβ/δ in kerotinocyte response to inflammation
50. Keratinocyte growth factor: A unique player in epithelial repair processes
51. Kerotinocyte activation in wounded skin
52. Is psoriasis a T-cell disease?
53. Prospects for prevention and treatment of cancer with selective PPAR-gamma modulators (SPARMs)
54. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth
55. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system
56. Peroxisome proliferator-activated receptors in inflammation control